Effects of aspirin for primary prevention of ASCVDs in DM type2 patients

Effects of aspirin for primary prevention of cardiovascular diseases in type 2 diabetes mellitus patients at Bangmulnak hospital, Phichit province

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20240328011

Enrollment

700

Registered

2024-03-28

Start date

2018-01-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Event in Type 2 diabetes patients Cardiovascular disease, Primary prevention, Aspirin, Type 2 diabetes

Interventions

DM patients with ASA use,DM patients without ASA use

Treatment,Treatment

ASA group,Non ASA group

Eligibility

Sex/Gender

All

Age

40 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Type 2 DM patients that were diagnosed and treatment at Bangmulnak Hospital.

Exclusion criteria

Exclusion criteria: 1. Patients with former history of cardiovascular diseases. 2. History of aspirin allergy. 3. Patients use other antiplatelet or anticoagulant.

Design outcomes

Primary

Measure	Time frame
Incident of CVD events 3 years after last enrolment Review of electrical medical records	—

Secondary

Measure	Time frame
N/A N/A N/A	—

Countries

Thailand

Contacts

Public ContactNathapol Phanachet

Bangmulnak hospital

nua036@gmail.com6656631131

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026